Convalescent donor SARS-COV-2-specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID-19 patients with severe disease has not received enough attention till date.
File(s)
Author(s)
Hanley, Brian
Roufosse, Candice A
Osborn, Michael
Naresh, Kikkeri N
Type
Journal Article
Date Issued
2020-05-19
Date Acceptance
2020-05-01
Citation
British Journal of Haematology, 2020, 189 (6), pp.1062-1063
ISSN
0007-1048
Publisher
Wiley
Start Page
1062
End Page
1063
Journal / Book Title
British Journal of Haematology
Volume
189
Issue
6
Copyright Statement
© 2020 British Society for Haematology and John Wiley & Sons Ltd. This is the accepted version of the following article: Hanley, B., Roufosse, C.A., Osborn, M. and Naresh, K.N. (2020), Convalescent donor SARS‐COV‐2‐specific cytotoxic T lymphocyte infusion as a possible treatment option for COVID‐19 patients with severe disease has not received enough attention till date. Br J Haematol, which has been published in final form at https://doi.org/10.1111/bjh.16780
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/32369628
Subjects
CD8+ T cells
COVID-19
NK cells
SARS-COV-2
cytotoxic cells
Publication Status
Published
Coverage Spatial
England
Date Publish Online
2020-05-05